Post-Trade Analysis: Autolus Therapeutics plc ADR (AUTL) Slides -1.35, Closing at 2.19

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

After finishing at $2.22 in the prior trading day, Autolus Therapeutics plc ADR (NASDAQ: AUTL) closed at $2.19, down -1.35%. In other words, the price has decreased by -$1.35 from its previous closing price. On the day, 0.67 million shares were traded. AUTL stock price reached its highest trading level at $2.28 during the session, while it also had its lowest trading level at $2.18.

Ratios:

Our goal is to gain a better understanding of AUTL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.64 and its Current Ratio is at 13.64. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.62.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 18, 2024, Upgraded its rating to Buy and sets its target price to $7.60 from $7 previously.

On November 15, 2024, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.

On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $10.Deutsche Bank initiated its Buy rating on November 09, 2023, with a $10 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’24 when Martin Pule bought 698,741 shares for $4.23 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUTL now has a Market Capitalization of 582807168 and an Enterprise Value of 226830256. For the stock, the TTM Price-to-Sale (P/S) ratio is 57.76 while its Price-to-Book (P/B) ratio in mrq is 1.22. Its current Enterprise Value per Revenue stands at 22.478 whereas that against EBITDA is -1.102.

Stock Price History:

Over the past 52 weeks, AUTL has reached a high of $7.37, while it has fallen to a 52-week low of $2.07. The 50-Day Moving Average of the stock is -20.72%, while the 200-Day Moving Average is calculated to be -42.02%.

Shares Statistics:

The stock has traded on average 1.88M shares per day over the past 3-months and 1057780 shares per day over the last 10 days, according to various share statistics. A total of 266.12M shares are outstanding, with a floating share count of 236.67M. Insiders hold about 11.06% of the company’s shares, while institutions hold 56.28% stake in the company. Shares short for AUTL as of 1735603200 were 8628285 with a Short Ratio of 4.59, compared to 1732838400 on 6293312. Therefore, it implies a Short% of Shares Outstanding of 8628285 and a Short% of Float of 4.37.

Earnings Estimates

The dynamic stock of Autolus Therapeutics plc ADR (AUTL) is currently attracting attention from 6.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.19 and low estimates of -$0.25.

Analysts are recommending an EPS of between -$0.67 and -$0.92 for the fiscal current year, implying an average EPS of -$0.84. EPS for the following year is -$0.74, with 8.0 analysts recommending between -$0.52 and -$0.93.

Revenue Estimates

A total of 8 analysts have provided revenue estimates for AUTL’s current fiscal year. The highest revenue estimate was $50M, while the lowest revenue estimate was $10.09M, resulting in an average revenue estimate of $17.33M. In the same quarter a year ago, actual revenue was $1.7MBased on 8 analysts’ estimates, the company’s revenue will be $50.85M in the next fiscal year. The high estimate is $119.15M and the low estimate is $18.34M.

Most Popular